3 min read FDA Moves to End Compounded Semaglutide and Tirzepatide What It Means for Weight Loss Patients The FDA Just Proposed a Major Change to Compounded Weight Loss Drugs If you've been following the news about weight loss medications, you may have heard that the FDA announced a significant regulatory change on April 30, 2026
Over the course of a month, a weekly injectable requires 4 doses
Thinking of buying Wegovy online
Under the regulations of the California Constitution, no runoff election was required
[8] Cagrilintide, by contrast, is not approved for any indication anywhere
Alternatives Medication only Limited to prescriptions without deeper insight or support Surface-level assessments Basic check-ins with no real understanding of root causes Generic protocols Brief, rushed visits with limited follow-up Little to no support Youre left to manage side effects, results, and progress alone Outdated approaches Recommendations not aligned with current research No long-term plan Focus on quick fixes rather than sustainable metabolic health Comprehensive care Integrated plan with medications, labs, and ongoing clinical guidance Biomarker-driven insights Advanced lab testing that reveals how your body is truly performing Personalized protocols Tailored plans based on your data, goals, and evolving biomarkers 1:1 coaching and guidance Support that helps you sustain habits and optimize long-term results Research-backed care Every protocol built on the latest metabolic and longevity science Continuous optimization Regular reviews, adjustments, and data tracking to keep you improving Science-backed metabolic care
